-
L.
Boots,
Philip
McKenna,
Beth
Arnold,
Paul
Keller,
M.
Gorny,
S.
Zolla-Pazner,
James
Robinson,
A.
Conley
(1997)
Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
AIDS research and human retroviruses, 13 18
-
E.
Park,
L.
Vujcic,
R.
Anand,
T.
Theodore,
G.
Quinnan,
(1998)
Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes
Journal of Virology, 72
-
B.
Watkins,
S.
Buge,
K.
Aldrich,
A.
Davis,
James
Robinson,
Marvin
Reitz,
M.
Robert-Guroff
(1996)
Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites
Journal of Virology, 70
-
D.
Burton,
C.
Barbas,
M.
Persson,
S.
Koenig,
R.
Chanock,
R.
Lerner
(1991)
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
Proceedings of the National Academy of Sciences of the United States of America, 88 22
-
Gorny M. K.
(1997)
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity
Rev. Infect. Dis., 159
-
R.
Wyatt,
John
Moore,
M.
Accola,
Elizabeth
Desjardin,
J.
Robinson,
J.
Sodroski
(1995)
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding
Journal of Virology, 69
-
F.
Fenner,
P.
Bachmann,
E.
Gibbs,
F.
Murphy,
M.
Studdert,
D.
White
(1968)
Immunization against Viral Diseases
The Medical Journal of Australia, 2
-
P.
Kwong,
R.
Wyatt,
James
Robinson,
R.
Sweet,
J.
Sodroski,
W.
Hendrickson
(1998)
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
Nature, 393
-
A.
Trkola,
M.
Purtscher,
T.
Muster,
C.
Ballaun,
A.
Buchacher,
N.
Sullivan,
K.
Srinivasan,
J.
Sodroski,
J.
Moore,
H.
Katinger
(1996)
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
Journal of Virology, 70
-
M.
Gorny,
V.
Gianakakos,
Sandra
Sharpe,
S.
Zolla-Pazner
(1989)
Generation of human monoclonal antibodies to human immunodeficiency virus.
Proceedings of the National Academy of Sciences of the United States of America, 86 5
-
R.
Weiss,
P.
Clapham,
M.
Mcclure,
J.
McKeating,
Á.
McKnight,
A.
Dalgleish,
Q.
Sattentau,
J.
Weber
(1988)
Human immunodeficiency viruses: neutralization and receptors.
Journal of acquired immune deficiency syndromes, 1 6
-
P.
Zhang,
Xi
Chen,
D.
Fu,
J.
Margolick,
G.
Quinnan,
(1999)
Primary Virus Envelope Cross-Reactivity of the Broadening Neutralizing Antibody Response during Early Chronic Human Immunodeficiency Virus Type 1 Infection
Journal of Virology, 73
-
M.
D’Souza,
P.
Durda,
C.
Hanson,
G.
Milman
(1991)
Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators.
AIDS, 5 9
-
E.
Park,
G.
Quinnan,
(1999)
Both Neutralization Resistance and High Infectivity Phenotypes Are Caused by Mutations of Interacting Residues in the Human Immunodeficiency Virus Type 1 gp41 Leucine Zipper and the gp120 Receptor- and Coreceptor-Binding Domains
Journal of Virology, 73
-
R.
Connor,
K.
Sheridan,
C.
Lai,
L.
Zhang,
D.
Ho
(1996)
Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection
Journal of Virology, 70
-
M.
Reitz,
Carolyn
Wilson,
C.
Naugle,
R.
Gallo,
M.
Robert-Guroff
(1988)
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene
Cell, 54
-
B.
Watkins,
M.
Reitz,
C.
Wilson,
K.
Aldrich,
A.
Davis,
M.
Robert-Guroff
(1993)
Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways
Journal of Virology, 67
-
Carolyn
Wilson,
Marvin
Reitz,
K.
Aldrich,
P.
Klasse,
J.
Blomberg,
R.
Gallo,
M.
Robert-Guroff
(1990)
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope
Journal of Virology, 64
-
B.
Bagwell
(1996)
A journey through flow cytometric immunofluorescence analyses—Finding accurate and robust algorithms that estimate positive fraction distributions
Clinical Immunology Newsletter, 16
-
P.
Wehrle
(1965)
IMMUNIZATION AGAINST VIRAL DISEASES.
California medicine, 103
-
Marshall
Posner,
L.
Cavacini,
Emes
Cl,
Jennifer
Power,
R.
Byrn
(1993)
Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.
Journal of acquired immune deficiency syndromes, 6 1
-
C.
Hioe,
Serena
Xu,
Padmasree
Chigurupati,
S.
Burda,
C.
Williams,
M.
Gorny,
S.
Zolla-Pazner
(1997)
Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies.
International immunology, 9 9
-
Marshall
Posner,
T.
Hideshima,
Thomas
Cannon,
M.
Mukherjee,
Kenneth
Mayer,
R.
Byrn
(1991)
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
Journal of immunology, 146 12
-
J.
Bagley,
P.
Dillon,
C.
Rosen,
J.
Robinson,
J.
Sodroski,
W.
Marasco
(1994)
Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.
Molecular immunology, 31 15
-
M.
Gorny,
J.
Xu,
V.
Gianakakos,
S.
Karwowska,
C.
Williams,
H.
Sheppard,
C.
Hanson,
S.
Zolla-Pazner
(1991)
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America, 88
-
M.
Purtscher,
A.
Trkola,
Andreas
Grassauer,
P.
Schulz,
A.
Klima,
S.
Döpper,
G.
Gruber,
A.
Buchacher,
T.
Muster,
H.
Katinger
(1996)
Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5
AIDS, 10
-
R.
Wyatt,
P.
Kwong,
E.
Desjardins,
R.
Sweet,
James
Robinson,
W.
Hendrickson,
J.
Sodroski
(1998)
The antigenic structure of the HIV gp120 envelope glycoprotein
Nature, 393
-
M.
Thali,
John
Moore,
C.
Furman,
M.
Charles,
D.
Ho,
J.
Robinson,
J.
Sodroski
(1993)
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
Journal of Virology, 67
-
M.
Gorny,
Jian
Xu,
S.
Karwowska,
A.
Buchbinder,
S.
Zolla-Pazner
(1993)
Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
Journal of immunology, 150 2
-
A.
Conley,
M.
Gorny,
J.
Kessler,
L.
Boots,
M.
Ossorio-Castro,
S.
Koenig,
D.
Lineberger,
E.
Emini,
C.
Williams,
S.
Zolla-Pazner
(1994)
Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D
Journal of Virology, 68
-
Jian-Yin
Xu,
M.
Gorny,
T.
Palker,
S.
Karwowska,
S.
Zolla-Pazner
(1991)
Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies
Journal of Virology, 65
-
A.
Buchacher,
R.
Predl,
K.
Strutzenberger,
W.
Steinfellner,
A.
Trkola,
M.
Purtscher,
G.
Gruber,
C.
Tauer,
F.
Steindl,
A.
Jungbauer,
H.
Katinger
(1994)
Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
AIDS research and human retroviruses, 10 4
-
L.
Stamatatos,
C.
Cheng‐Mayer
(1998)
An Envelope Modification That Renders a Primary, Neutralization-Resistant Clade B Human Immunodeficiency Virus Type 1 Isolate Highly Susceptible to Neutralization by Sera from Other Clades
Journal of Virology, 72
-
P.
Roben,
John
Moore,
M.
Thali,
J.
Sodroski,
C.
Barbas,
D.
Burton
(1994)
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
Journal of Virology, 68
-
Gorny M. K.
(1993)
Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120
Rev. Infect. Dis., 150
-
M.
Gorny,
T.
Vancott,
C.
Hioe,
Z.
Israel,
Nelson
Michael,
A.
Conley,
C.
Williams,
Joseph
Kessler,
P.
Chigurupati,
S.
Burda,
S.
Zolla-Pazner
(1997)
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
Journal of immunology, 159 10
-
J.
Moore,
Alexandra
Trkola,
B.
Korber,
L.
Boots,
Joseph
Kessler,
F.
McCutchan,
J.
Mascola,
HO
DAVIDD.,
James
Robinson,
A.
Conley
(1995)
A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B
Journal of Virology, 69
-
C.
Barbas,
James
Crowe,
Doug
Cababa,
Teresa
Jones,
S.
Zebedee,
B.
Murphy,
R.
Chanock,
D.
Burton
(1992)
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.
Proceedings of the National Academy of Sciences of the United States of America, 89 21
-
Posner M. R.
(1991)
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection
Rev. Infect. Dis., 146
-
M.
Thali,
M.
Charles,
C.
Furman,
L.
Cavacini,
M.
Posner,
J.
Robinson,
J.
Sodroski
(1994)
Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change
Journal of Virology, 68